DEF 14A

Company

Damora Therapeutics, Inc.

Filed

December 31, 2025

Period of Report

February 9, 2026

Accession Number

0001140361-25-047056

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →